CYP1A2
E561029
CYP1A2 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs and xenobiotics.
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
cytochrome P450 enzyme
ⓘ
drug-metabolizing enzyme ⓘ protein ⓘ |
| affects |
clearance of caffeine
ⓘ
clearance of clozapine ⓘ clearance of theophylline ⓘ |
| biologicalProcess |
drug metabolism
ⓘ
oxidation-reduction process ⓘ xenobiotic metabolic process ⓘ |
| chromosomalLocation | 15q24.1 ⓘ |
| encodes | cytochrome P450 1A2 protein ⓘ |
| expressedIn | liver ⓘ |
| gene | CYP1A2 NERFINISHED ⓘ |
| hasMolecularFunction |
monooxygenase activity
ⓘ
oxidoreductase activity ⓘ |
| inducedBy |
cruciferous vegetables
ⓘ
omeprazole ⓘ polycyclic aromatic hydrocarbons ⓘ smoking ⓘ |
| inhibitedBy |
cimetidine
ⓘ
ciprofloxacin ⓘ enoxacin ⓘ fluoroquinolone antibiotics ⓘ fluvoxamine ⓘ oral contraceptives ⓘ |
| locatedIn | endoplasmic reticulum membrane ⓘ |
| memberOf |
CYP1 family
NERFINISHED
ⓘ
CYP1A subfamily NERFINISHED ⓘ cytochrome P450 superfamily NERFINISHED ⓘ |
| organism | Homo sapiens ⓘ |
| polymorphismAssociatedWith |
risk of adverse drug reactions
ⓘ
variation in caffeine metabolism ⓘ variation in drug response ⓘ |
| regulatedBy | aryl hydrocarbon receptor ⓘ |
| substrateOf |
aflatoxin B1
ⓘ
amitriptyline NERFINISHED ⓘ caffeine ⓘ clozapine NERFINISHED ⓘ duloxetine ⓘ imipramine NERFINISHED ⓘ olanzapine ⓘ phenacetin ⓘ polycyclic aromatic hydrocarbons ⓘ rasagiline ⓘ tacrine ⓘ theophylline NERFINISHED ⓘ tizanidine ⓘ warfarin ⓘ |
| usesCofactor |
NADPH
ⓘ
heme ⓘ |
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
Riluzole